MedCity News
OCTOBER 30, 2022
We’ve been talking about improving patient satisfaction and creating a more patient-centric care experience for years. But we’ll never get there if we continue to be focused on transactional healthcare, which is where our efforts toward interoperability have traditionally been drawn.
Pharmaceutical Technology
OCTOBER 30, 2022
Concept: Massachusetts Institute of Technology (MIT)’s Computer Science and Artificial Intelligence Laboratory (CSAIL) researchers have developed a system called ‘series elastic end effectors’ (SEED) that enable robots to use grabbed tools correctly and successfully. It was developed in partnership with the American Toyota Research Institute (a technology research unit of Toyota).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
OCTOBER 30, 2022
Mayo Clinic teamed up with digital health platform Memora Health to pilot a new initiative for postpartum patients. They are launching a texting-based program to better engage postpartum patients and have entered a research collaboration to measure the model’s efficacy.
Clarivate
OCTOBER 30, 2022
Amid an escalation in the marketing of digital therapeutics (DTx) that diagnose, treat and/or manage health conditions in the United States, the federal government has yet to establish a coverage policy for these software-based interventions for the Medicare population. While some lawmakers seek to change that, United States managed care organizations (MCOs) are moving ahead and covering DTx in commercial plans, particularly for mental health conditions.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
OCTOBER 30, 2022
Targeted drugs and immunotherapies are among the advances that contribute to declines in incidence and deaths from non-small cell lung cancer, according to the Annual Report to the Nation on the Status of Cancer. But the trends are on the rise for some other cancers and racial disparities persist, highlighting the need to better understand these differences.
Pharmaceutical Technology
OCTOBER 30, 2022
Concept: Florida-based startup Undefined Technologies (Undefined) has tested the flight of its electric vertical take-off and landing (eVTOL) ion propulsion drone called Silent Ventus. The eVTOL has the potential to redefine dual-purpose cargo delivery drones. Nature of Disruption: Silent Ventus uses patented technology to produce an ‘ionic wind’ that propels the vehicle in the desired direction by ionizing oxygen and nitrogen molecules in the surrounding air.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmaceutical Technology
OCTOBER 30, 2022
Concept: Canadian software development startup Minerva Intelligence has launched an AI-powered application programming interface (API) called climate85 API for climate risk data. It offers the ability to measure the effects of climate change on business owners, investors, and portfolio managers. Nature of Disruption: climate85 API comprises comprehensive climate risk datasets which are created using advanced scientific methodologies and are based on a selected group of global climate models and
pharmaphorum
OCTOBER 30, 2022
Shares in US biotech Y-mAbs Therapeutics have lost almost a third of their value after FDA advisors unanimously rejected its brain cancer therapy 131I-omburtamab in 16 to 0 vote. The Oncologic Drugs Advisory Committee (ODAC) concluded that Y-mAbs had not provided sufficient evidence that omburtamab was able to improve overall survival in children with neuroblastoma that had spread to the central nervous system or leptomeninges – the thin layers of tissue that cover the brain and spinal cord.
Pharmaceutical Technology
OCTOBER 30, 2022
Concept: German pharmaceutical and biotechnology company Bayer has partnered with American Perdue AgriBusiness (Perdue), an operating company of Perdue Farms for regenerative farming. The duo aims to significantly reduce carbon emissions and develop a model for a more sustainable food value chain that includes the entire Perdue grain network. Nature of Disruption: The partnership is based on Bayer's ‘ForGround’ platform and leverages the capabilities and size of both organizations to develop a m
MedCity News
OCTOBER 30, 2022
Average annual premiums in 2022 reached $7,911 for single coverage and $22,463 for family coverage, the KFF survey showed. This is only a slight increase from last year at $7,739 and $22,221, respectively.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
OCTOBER 30, 2022
Concept: Robert Bosch (Bosch) has developed a surround sensing and collision warning system for more precise construction vehicle maneuvering. It has also partnered with Bosch Rexroth to deliver the off-highway robotics controller (ORC). The ORC is a potent control module that serves as the brain of the automated machine and offers the ability to support and relieve pressure in challenging use cases.
Expert insights. Personalized for you.
144 
Let's personalize your content